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Background
Hereditary Angioedema (HAE) is an autosomal domi-
nant disorder resulting from a deficiency of C1 esterase
inhibitor (C1-INH). It is a rare disease with clinical
manifestations debilitating and potentially fatal. The aim
of this study was to report the clinical and laboratory
characteristics and treatment of patients with Hereditary
Angioedema with C1-INH deficit Outpatient Immunol-
ogy University.
Methods
This was a retrospective study using data from the clini-
cal records of patients with confirmed HAE with C1-INH
diagnosis. The laboratory diagnosis was made after
dosages of C4 and C1-INH and functional study of
C1-INH (Technoclone® kit). Age at time of first appoint-
ment, onset of symptoms, time to diagnosis, clinical man-
ifestations, prodrome, angioedema triggered the crisis,
the need for hospitalization, prophylactic treatment and
medication used for seizures were analyzed.
Results
Were included 30 patients (22F:8M; 16 days of age – 51
years old) diagnosed in the last 2 years. The first symp-
toms occurred: (6/30; 20%) before 2 years old; (6/30; 20%),
most of cases (10/30; 33,3%) ocurred in the adolescence
and two patients were asymptomatic. The following clini-
cal manifestations were reported: subcutaneous edema in
86%; 56.6% affecting the face; abdominal pain in 80% and
33.3% of them were submited to abdominal surgery; 46.6%
reported asphyxia and 28,5% had voice changing. Prodro-
mal symptoms were referred in 36.6%: cutaneous rash, tin-
gling and pruritus, triggering factors were: trauma (6/30;
53.3 %), stress (17/30; 56.6%) and pregnancy was reported
by 4 patients. Hospitalization was referred by 63.3% and
out of them, 21% in Intensive Care Unity (ICU). Therapy
was employed: danazol (14/30), oxandrolon (13/30) and
tranexamic acid (15/30), plasma (4/30). Icatibant was
available and applied in 12 patients.
Conclusions
Clinical manifestations did not differ from the previous
reports. It was relevant the high frequency of hospitaliza-
tion as well as ICU admission. This situation reflects the
restricted access to therapy of the attacks. In addition, pre-
vious abdominal surgery was also reported in a third of
the patients. Although the knowledge about HAE has
improved in our country, the access to therapy and man-
agement as a whole are still restricted.
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